EQUIPED-ADRD: Enhanced Quality in Primary Care for Elders With Diabetes and Dementia
Study Details
Study Description
Brief Summary
The purpose of this study is to develop and test a care quality improvement intervention featuring use of consensus decisional guidance for the medical management of diabetes (DM) in patients with Alzheimer's disease and related dementia (ADRD) in primary care, provider (PCP) workflow enhancements supported by a panel manager(PM) for workflow support, electronic health record (EHR) decision support and feedback, and PCP collaborative learning.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Intervention (INT) (10 clinic sites and ~500 patients) which includes practice guidelines for clinicians, provider education, electronic health record support for quality DM-ADRD care, information about community/clinical resources, ongoing targeted provider feedback, and a panel manager (PM) |
Behavioral: EQUIPED-ADRD Intervention
(10 clinic sites and ~500 patients) which includes practice guidelines for clinicians, provider education, electronic health record support for quality DM-ADRD care, information about community/clinical resources, ongoing targeted provider feedback, and a panel manager (PM)
|
| Placebo Comparator: Control (CON) During training the CON providers will be encouraged to do cognitive screening as well as follow the guidelines in general. |
Behavioral: Control (CON)
Will use current guidelines for primary care treatment with Diabetes and Dementia
|
Outcome Measures
Primary Outcome Measures
- Proportion of Intervention patients reaching consensus target HbA1c [30 Months]
- Proportion of Control patients reaching consensus target HbA1c [30 Months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient must receive care at participating NYU FGP clinics.
-
Patient must be English or Spanish speaking.
-
Patient must have DM diagnosis.
-
Patient must have documented cognitive impairment or an ADRD diagnosis.
-
Patient must have someone who is identified as a family or friend who provides caregiving assistance.
Caregiver:
-
Caregiver must have adequate knowledge of identified patient and/or participate in that member's healthcare decisions.
-
Caregiver must be English or Spanish speaking.
-
Caregiver must demonstrate capacity to consent to research participation.
-
Caregiver must be at least 21 years old.
Exclusion Criteria:
Patient:
-
Patient does not receive care at participating NYU FGP clinics.
-
Patient is not 65 years and older.
-
Patient is not English or Spanish speaking.
-
Patient does not have DM diagnosis.
-
Patient does not have documented Cognitive impairment or an ADRD diagnosis.
-
Patient has severe dementia, other terminal illness with <6 months to live, and/or is hospice eligible.
-
Patient does not have a caregiver.
Caregiver:
-
Caregiver does not have adequate knowledge of identified patient and/or does not participate in that member's healthcare decisions.
-
Caregiver is not English or Spanish speaking.
-
Caregiver lacks capacity to consent to research.
-
Caregiver is under 21 years old.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | NYU Langone Health | New York | New York | United States | 10016 |
Sponsors and Collaborators
- NYU Langone Health
- National Institute on Aging (NIA)
Investigators
- Principal Investigator: Joshua Chodosh, MD, MSHS, FACP, NYU Langone Health
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- s18-01166
- 1R21AG057291-01